These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 28620095)

  • 21. JAKs and STATs in immunity, immunodeficiency, and cancer.
    O'Shea JJ; Holland SM; Staudt LM
    N Engl J Med; 2013 Jan; 368(2):161-70. PubMed ID: 23301733
    [No Abstract]   [Full Text] [Related]  

  • 22. Human diseases caused by impaired signal transducer and activator of transcription and Janus kinase signaling.
    Chaimowitz NS; Forbes LR
    Curr Opin Pediatr; 2019 Dec; 31(6):843-850. PubMed ID: 31693596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HiJAKing the epigenome in leukemia and lymphoma.
    Drennan AC; Rui L
    Leuk Lymphoma; 2017 Nov; 58(11):2540-2547. PubMed ID: 28402164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Non-Receptor Protein Tyrosine Phosphatase PTPN6 Mediates a Positive Regulatory Approach From the Interferon Regulatory Factor to the JAK/STAT Pathway in
    Luo M; Xu X; Liu X; Shen W; Yang L; Zhu Z; Weng S; He J; Zuo H
    Front Immunol; 2022; 13():913955. PubMed ID: 35844582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STAT activation and differential complex formation dictate selectivity of interferon responses.
    Wesoly J; Szweykowska-Kulinska Z; Bluyssen HA
    Acta Biochim Pol; 2007; 54(1):27-38. PubMed ID: 17351669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukins and STAT signaling.
    Haque SJ; Sharma P
    Vitam Horm; 2006; 74():165-206. PubMed ID: 17027515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential activation of JAKs, STATs and xanthine dehydrogenase/oxidase by hypoxia in lung microvascular endothelial cells.
    Wang G; Qian P; Jackson FR; Qian G; Wu G
    Int J Biochem Cell Biol; 2008; 40(3):461-70. PubMed ID: 17920330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging roles of JAK-STAT signaling pathways in adipocytes.
    Richard AJ; Stephens JM
    Trends Endocrinol Metab; 2011 Aug; 22(8):325-32. PubMed ID: 21561789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. JAKs and STATs branch out.
    Briscoe J; Kohlhuber F; Müller M
    Trends Cell Biol; 1996 Sep; 6(9):336-40. PubMed ID: 15157430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon signal transduction.
    Larner A; Reich NC
    Biotherapy; 1996; 8(3-4):175-81. PubMed ID: 8813329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Jak-STAT signaling pathways in cells of the immune system.
    Ivashkiv LB
    Rev Immunogenet; 2000; 2(2):220-30. PubMed ID: 11258419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Jaks and Stats in cytokine signaling.
    Ihle JN; Nosaka T; Thierfelder W; Quelle FW; Shimoda K
    Stem Cells; 1997; 15 Suppl 1():105-11; discussion 112. PubMed ID: 9368330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysregulation of janus kinases and signal transducers and activators of transcription in cancer.
    Costa-Pereira AP; Bonito NA; Seckl MJ
    Am J Cancer Res; 2011; 1(6):806-16. PubMed ID: 22016828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noncanonical IFN Signaling, Steroids, and STATs: A Probable Role of V-ATPase.
    Johnson HM; Noon-Song E; Ahmed CM
    Mediators Inflamm; 2019; 2019():4143604. PubMed ID: 31275057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. STAT proteins in innate immunity during sepsis: lessons from gene knockout mice.
    Matsukawa A
    Acta Med Okayama; 2007 Oct; 61(5):239-45. PubMed ID: 17971840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signal transduction in the interferon system.
    Haque SJ; Williams BR
    Semin Oncol; 1998 Feb; 25(1 Suppl 1):14-22. PubMed ID: 9482536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon research: impact on understanding transcriptional control.
    Darnell JE
    Curr Top Microbiol Immunol; 2007; 316():155-63. PubMed ID: 17969447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. JAKs to STATs: A tantalizing therapeutic target in acute myeloid leukemia.
    Venugopal S; Bar-Natan M; Mascarenhas JO
    Blood Rev; 2020 Mar; 40():100634. PubMed ID: 31677846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. JAKs go nuclear: emerging role of nuclear JAK1 and JAK2 in gene expression and cell growth.
    Zouein FA; Duhé RJ; Booz GW
    Growth Factors; 2011 Dec; 29(6):245-52. PubMed ID: 21892841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Why Do We Need JAK Inhibitors in Systemic Lupus Erythematosus?
    Richter P; Cardoneanu A; Burlui AM; Macovei LA; Bratoiu I; Buliga-Finis ON; Rezus E
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.